PHARMA BASE
ActiveSummary
The computed 12-month bankruptcy probability of PHARMA BASE is 3.4% (moderate). The 2024 annual accounts show equity of €2.5m and a net result of €178,876. Equity remains stable across the filed financial years (±2.4% per year). Its solvency ranks better than 16% of 6,072 sector peers (NACE 46, financial year 2024). The company has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Part of the group
peeters mathieu management
7 companies
Group, risk and exposure
Connections & network
No directors read yet: 0 of 21 Gazette acts processed.